Stock Events

Stock Events

Pharmacom Biovet 

$0.000100
4
+$0.00+0%Thursday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.0001
52W Low
0.000001
Volume
150,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 19Expected
Q4 2003
Q1 2004
Q2 2004
Q3 2004
-0.34
-0.23
-0.11
0
Expected EPS
0
Actual EPS
-0.2

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap28.8B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Pharmacom Biovet's product offerings.
Elanco Animal Health
ELAN
Mkt Cap11.06B
Elanco Animal Health Incorporated operates in the same industry, focusing on innovating, developing, and marketing products to improve animal health, which puts them in direct competition with Pharmacom Biovet.
Idexx Laboratories
IDXX
Mkt Cap40.84B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information products to the animal health industry, competing with Pharmacom Biovet in the veterinary diagnostics market.
Abbott Laboratories
ABT
Mkt Cap168.71B
Abbott Laboratories, through its diagnostics and medical devices, serves the veterinary sector as well, making it a competitor in areas where Pharmacom Biovet operates.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc., with its diversified portfolio, includes veterinary health products that compete with Pharmacom Biovet's offerings in the pharmaceuticals and health solutions sector.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. has a division focused on animal health, producing vaccines and pharmaceuticals for animals, which competes with Pharmacom Biovet's product lines.
Phibro Animal Health
PAHC
Mkt Cap1.51B
Phibro Animal Health Corporation operates in the same sector, providing animal health and nutritional products across the globe, which positions them as a competitor to Pharmacom Biovet.

About

PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds. Established in 1995, the company was previously known as ABV Gold Inc. before officially changing its name to PharmaCom BioVet, Inc. in August 2008. Its corporate base is located in Raleigh, North Carolina.
Show More
CEO
Ira Frohman
Country
United States
ISIN
US71720A1079

Listings

OTC Link
US
PHMB

0 Comments

Share your thoughts

FAQs

What is Pharmacom Biovet stock price today?▼
The current price of PHMB is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Pharmacom Biovet stock price performance more closely on the chart.
What is Pharmacom Biovet stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Pharmacom Biovet stocks are traded under the ticker PHMB.
What were Pharmacom Biovet earnings last quarter?▼
PHMB earnings for the last quarter are -0.2 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Pharmacom Biovet located?▼
Pharmacom Biovet operates in the Health & Wellness sector.
When did Pharmacom Biovet complete a stock split?▼
The last stock split for Pharmacom Biovet was on September 10, 2008 with a ratio of 1:15.
Where is Pharmacom Biovet headquartered?▼
Pharmacom Biovet is headquartered in Raleigh, United States.